Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unitary pricing bill pending in New Mexico; bills expected in 30 states.

Executive Summary

PhRMA/NACDS DEBATE PRICING LAWS: NEW MEXICO IS NEXT FORUM, with a unitary pricing/equal access bill scheduled to be considered in the state Senate the week of March 6. New Mexico's House approved the measure by a 40-25 vote Feb. 24. A similar bill passed both state chambers handily last session but was vetoed by then-Gov. King (D). New Mexico is one of 30 states in which pricing legislation is actively being considered by the legislature or being drafted for introduction later in the session.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025860

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel